ProDentim is a chewable oral supplement designed to support dental and gum health by restoring balance to the oral microbiome. Launched in early 2023, the product has been used by over 133,000 individuals and maintains an average rating above 4.8 stars (prodantimm.com).

Developed under the direction of Dr. Drew Sutton, a U.S.-based otolaryngologist, ProDentim is manufactured in FDA-registered and GMP-certified facilities located in the United States, following stringent production protocols for quality, traceability, purity, and safety (globenewswire.com).

Although dietary supplements are not required to receive direct FDA approval, ProDentim is produced in facilities regulated by the FDA, meeting U.S. standards for supplement safety and quality. The manufacturing environment complies with the Dietary Supplement Health and Education Act (DSHEA) and uses non-GMO and gluten-free components (globenewswire.com).

Each bottle contains 30 soft tablets, delivering 3.5 billion CFU per dose through a combination of probiotic strains (Lactobacillus paracasei ET-22, Lactobacillus reuteri DSM 17938, Bifidobacterium lactis BL-04, and Streptococcus salivarius), combined with prebiotic inulin, malic acid (from strawberries), tricalcium phosphate, and natural flavoring agents.

Clinical feedback suggests users notice improvements in breath freshness, gum sensitivity, and inflammation within a few weeks of use. No significant adverse effects have been reported even after up to 6 months of continued use.